Rainer Henning, Chief Executive Officer

Viravaxx
discovery, research and development Rainer Henning
Chief Executive Officer

Welcome by the CEO

Viravaxx is sponsoring a clinical Trial with its novel Hepatitis B vaccine VVX001. We are currently looking for volunteers interested in participation in this study. If you are living in Vienna or vicinity, please take a look at the following information about this study.

Information on clinical study with VVX001